Evaluating the Effectiveness of Combined T4 and T3 Therapy or Desiccated Thyroid Versus T4 Monotherapy in Hypothyroidism: a Systematic Review and Meta-analysis

Overview

Journal BMC Endocr Disord

Publisher Biomed Central

Specialty Endocrinology

Date 2024 Jun 14

PMID 38877429

Authors

Mahmoud Nassar

Ahmed Hassan

Shrouk Ramadan

Mariam Tarek Desouki

Malak A Hassan

Ajay Chaudhuri

Affiliations

Soon will be listed here.

Abstract

Background: Persistent symptoms in hypothyroid patients despite normalized TSH levels suggest the need for alternative treatments. This study aims to evaluate the effectiveness of combined T4 and T3 therapy or desiccated thyroid (DTE) compared to T4 monotherapy, with a focus on thyroid profile, lipid profile, and quality of life metrics.

Methods: We conducted a systematic review in Embase, Medline/PubMed, and Web of Science up to 11/23/2023. We used the following keywords: "Armour Thyroid," OR "Thyroid extract," OR "Natural desiccated thyroid," OR "Nature-Throid," "desiccated thyroid," OR "np thyroid," OR "Synthroid," OR "levothyroxine," OR "Liothyronine," "Cytomel," OR "Thyroid USP," OR "Unithroid." AND "hypothyroidism. " We only included RCTs and excluded non-RCT, case-control studies, and non-English articles.

Results: From 6,394 identified records, 16 studies qualified after screening and eligibility checks. We included two studies on desiccated thyroid and 15 studies on combined therapy. In this meta-analysis, combination therapy with T4 + T3 revealed significantly lower Free T4 levels (mean difference (MD): -0.34; 95% CI: -0.47, -0.20), Total T4 levels (mean difference: -2.20; 95% CI: -3.03, -1.37), and GHQ-28 scores (MD: -2.89; 95% CI: -3.16, -2.63), compared to T4 monotherapy. Total T3 levels were significantly higher in combined therapy (MD: 29.82; 95% CI: 22.40, 37.25). The analyses demonstrated moderate to high heterogeneity. There was no significant difference in Heart Rate, SHBG, TSH, Lipid profile, TSQ-36, and BDI Score. Subjects on DTE had significantly higher serum Total T3 levels (MD: 50.90; 95% CI: 42.39, 59.42) and significantly lower serum Total T4 (MD: -3.11; 95% CI: -3.64, -2.58) and Free T4 levels (MD: -0.50; 95% CI: -0.57, -0.43) compared to T4 monotherapy. Moreover, DTE treatment showed modestly higher TSH levels (MD: 0.49; 95% CI: 0.17, 0.80). The analyses indicated low heterogeneity. There was no significant difference in Heart Rate, SHBG, Lipid profile, TSQ-36, GHQ-28, and BDI Score.

Conclusions: Our study revealed that combined therapy and DTE lead to higher T3 and lower T4 levels, compared to T4 monotherapy in hypothyroidism. However, no significant effects on heart rate, lipid profile, or quality of life were noted. Given the heterogeneity of results, personalized treatment approaches are recommended.

Citing Articles

LT4/LT3 Combination Therapy vs. Monotherapy with LT4 for Persistent Symptoms of Hypothyroidism: A Systematic Review.

Vargas-Uricoechea H, Wartofsky L Int J Mol Sci. 2024; 25(17).

PMID: 39273168 PMC: 11395006. DOI: 10.3390/ijms25179218.

References

Nygaard B, Jensen E, Kvetny J, Jarlov A, Faber J . Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol. 2009; 161(6):895-902. DOI: 10.1530/EJE-09-0542. View

Schmidt U, Nygaard B, Jensen E, Kvetny J, Jarlov A, Faber J . Peripheral markers of thyroid function: the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study. Endocr Connect. 2013; 2(1):55-60. PMC: 3680960. DOI: 10.1530/EC-12-0064. View

Ettleson M, Bianco A . Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?. J Clin Endocrinol Metab. 2020; 105(9). PMC: 7382053. DOI: 10.1210/clinem/dgaa430. View

Biondi B, Wartofsky L . Treatment with thyroid hormone. Endocr Rev. 2014; 35(3):433-512. DOI: 10.1210/er.2013-1083. View

Shakir M, Brooks D, McAninch E, Fonseca T, Mai V, Bianco A . Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism. J Clin Endocrinol Metab. 2021; 106(11):e4400-e4413. PMC: 8530721. DOI: 10.1210/clinem/dgab478. View

McDermott M . Hypothyroidism. Ann Intern Med. 2020; 173(1):ITC1-ITC16. DOI: 10.7326/AITC202007070. View

Rodriguez T, Lavis V, Meininger J, Kapadia A, Stafford L . Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract. 2005; 11(4):223-33. PMC: 1455482. DOI: 10.4158/EP.11.4.223. View

Mateo R, Hennessey J . Thyroxine and treatment of hypothyroidism: seven decades of experience. Endocrine. 2019; 66(1):10-17. PMC: 6794242. DOI: 10.1007/s12020-019-02006-8. View

Fadeyev V, Morgunova T, Melnichenko G, Dedov I . Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism. Hormones (Athens). 2010; 9(3):245-52. DOI: 10.14310/horm.2002.1274. View

10.

Hughes K, Eastman C . Thyroid disease: Long-term management of hyperthyroidism and hypothyroidism. Aust J Gen Pract. 2021; 50(1-2):36-42. DOI: 10.31128/AJGP-09-20-5653. View

11.

Escobar-Morreale H, Botella-Carretero J, del Rey F, Morreale de Escobar G . REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab. 2005; 90(8):4946-54. DOI: 10.1210/jc.2005-0184. View

12.

Wartofsky L . Combination L-T3 and L-T4 therapy for hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2013; 20(5):460-6. DOI: 10.1097/01.med.0000432611.03732.49. View

13.

Saravanan P, Siddique H, Simmons D, Greenwood R, Dayan C . Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy. Exp Clin Endocrinol Diabetes. 2007; 115(4):261-7. DOI: 10.1055/s-2007-973071. View

14.

Walsh J, Shiels L, Lim E, Bhagat C, Ward L, Stuckey B . Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab. 2003; 88(10):4543-50. DOI: 10.1210/jc.2003-030249. View

15.

Siegmund W, Spieker K, Weike A, Giessmann T, Modess C, Dabers T . Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf). 2004; 60(6):750-7. DOI: 10.1111/j.1365-2265.2004.02050.x. View

16.

Sawka A, Gerstein H, Marriott M, MacQueen G, Joffe R . Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003; 88(10):4551-5. DOI: 10.1210/jc.2003-030139. View

17.

Clyde P, Harari A, Getka E, Shakir K . Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003; 290(22):2952-8. DOI: 10.1001/jama.290.22.2952. View

18.

Valizadeh M, Seyyed-Majidi M, Hajibeigloo H, Momtazi S, Musavinasab N, Hayatbakhsh M . Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial. Endocr Res. 2009; 34(3):80-9. DOI: 10.1080/07435800903156340. View

19.

Turpin S, Lambert R, Deal C . Timing of Hormone Withdrawal in Children Undergoing 131I Whole-Body Scans for Thyroid Cancer. Horm Res Paediatr. 2016; 86(6):410-415. DOI: 10.1159/000453064. View

20.

Millan-Alanis J, Gonzalez-Gonzalez J, Flores-Rodriguez A, Ospina N, Maraka S, Moreno-Pena P . Benefits and Harms of Levothyroxine/L-Triiodothyronine Versus Levothyroxine Monotherapy for Adult Patients with Hypothyroidism: Systematic Review and Meta-Analysis. Thyroid. 2021; 31(11):1613-1625. PMC: 8917901. DOI: 10.1089/thy.2021.0270. View